KR20070100331A - 새로운 아데노신 에이3 수용체 조절제 - Google Patents
새로운 아데노신 에이3 수용체 조절제 Download PDFInfo
- Publication number
- KR20070100331A KR20070100331A KR1020077017126A KR20077017126A KR20070100331A KR 20070100331 A KR20070100331 A KR 20070100331A KR 1020077017126 A KR1020077017126 A KR 1020077017126A KR 20077017126 A KR20077017126 A KR 20077017126A KR 20070100331 A KR20070100331 A KR 20070100331A
- Authority
- KR
- South Korea
- Prior art keywords
- dione
- compound
- purine
- substituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CCC*(C(*(Cc1ccccc1)C(CC=C=C(C)COC)=C1*)=O)C1=O Chemical compound CCC*(C(*(Cc1ccccc1)C(CC=C=C(C)COC)=C1*)=O)C1=O 0.000 description 1
- IKKRCMAXZREWHW-UHFFFAOYSA-N CCCN(C(C(N)=C(N)N1Cc2ccccc2)=O)C1=O Chemical compound CCCN(C(C(N)=C(N)N1Cc2ccccc2)=O)C1=O IKKRCMAXZREWHW-UHFFFAOYSA-N 0.000 description 1
- HWLZWMZDBLPNOK-UHFFFAOYSA-N CCCN(C(c1c(N2Cc3ccccc3)nc[nH]1)=O)C2=O Chemical compound CCCN(C(c1c(N2Cc3ccccc3)nc[nH]1)=O)C2=O HWLZWMZDBLPNOK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64972605P | 2005-02-02 | 2005-02-02 | |
| US60/649,726 | 2005-02-02 | ||
| US11/344,295 | 2006-01-31 | ||
| US11/344,295 US7435740B2 (en) | 2005-02-02 | 2006-01-31 | Adenosine A3 receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20070100331A true KR20070100331A (ko) | 2007-10-10 |
Family
ID=36777854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020077017126A Ceased KR20070100331A (ko) | 2005-02-02 | 2006-02-01 | 새로운 아데노신 에이3 수용체 조절제 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7435740B2 (enExample) |
| EP (1) | EP1845993A4 (enExample) |
| JP (1) | JP2008538099A (enExample) |
| KR (1) | KR20070100331A (enExample) |
| AU (1) | AU2006210817B2 (enExample) |
| BR (1) | BRPI0606750A2 (enExample) |
| CA (1) | CA2596612A1 (enExample) |
| IL (1) | IL184532A0 (enExample) |
| MX (1) | MX2007008501A (enExample) |
| NZ (1) | NZ556649A (enExample) |
| WO (1) | WO2006083916A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090088403A1 (en) * | 2007-05-07 | 2009-04-02 | Randy Blakely | A3 adenosine receptors as targets for the modulation of central serotonergic signaling |
| WO2009092602A2 (en) * | 2008-01-24 | 2009-07-30 | Universität Zürich | Anti-angiogenic compounds |
| US20110190324A1 (en) * | 2008-07-16 | 2011-08-04 | Edward Leung | Methods of treating atherosclerosis |
| EP2456419B1 (en) | 2009-07-21 | 2016-11-23 | Oradin Pharmaceutical Ltd. | A3 adenosine receptor ligands for modulation of pigmentation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586429B2 (en) * | 2000-11-29 | 2003-07-01 | Cell Therapeutics, Inc. | Tricyclic fused xanthine compounds and their uses |
-
2006
- 2006-01-31 US US11/344,295 patent/US7435740B2/en not_active Expired - Fee Related
- 2006-02-01 AU AU2006210817A patent/AU2006210817B2/en not_active Ceased
- 2006-02-01 EP EP06734138A patent/EP1845993A4/en not_active Withdrawn
- 2006-02-01 KR KR1020077017126A patent/KR20070100331A/ko not_active Ceased
- 2006-02-01 BR BRPI0606750-6A patent/BRPI0606750A2/pt not_active IP Right Cessation
- 2006-02-01 JP JP2007554173A patent/JP2008538099A/ja not_active Withdrawn
- 2006-02-01 CA CA002596612A patent/CA2596612A1/en not_active Abandoned
- 2006-02-01 MX MX2007008501A patent/MX2007008501A/es active IP Right Grant
- 2006-02-01 NZ NZ556649A patent/NZ556649A/en not_active IP Right Cessation
- 2006-02-01 WO PCT/US2006/003477 patent/WO2006083916A2/en not_active Ceased
-
2007
- 2007-07-10 IL IL184532A patent/IL184532A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7435740B2 (en) | 2008-10-14 |
| NZ556649A (en) | 2010-03-26 |
| AU2006210817A2 (en) | 2006-08-10 |
| IL184532A0 (en) | 2007-10-31 |
| WO2006083916A2 (en) | 2006-08-10 |
| AU2006210817A1 (en) | 2006-08-10 |
| AU2006210817B2 (en) | 2010-12-23 |
| JP2008538099A (ja) | 2008-10-09 |
| WO2006083916A3 (en) | 2007-12-21 |
| EP1845993A4 (en) | 2009-03-11 |
| BRPI0606750A2 (pt) | 2009-07-14 |
| CA2596612A1 (en) | 2006-08-10 |
| US20060178385A1 (en) | 2006-08-10 |
| EP1845993A2 (en) | 2007-10-24 |
| MX2007008501A (es) | 2007-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7675777B2 (ja) | 免疫調節剤としての複素環式化合物 | |
| KR101227738B1 (ko) | 유기 화합물 | |
| JP5492565B2 (ja) | Ｊａｎｕｓキナーゼ阻害剤としての置換複素環 | |
| TWI791593B (zh) | 做為腺苷受體拮抗劑之苯并咪唑衍生物 | |
| JP7287951B2 (ja) | アデノシン受容体アンタゴニストとしてのキノキサリン誘導体 | |
| JP7600119B2 (ja) | アデノシン受容体アンタゴニストとしてのチアゾロピリジン誘導体 | |
| JP2025160175A (ja) | Ｃｄ３８阻害剤としてのキノリン及びアザキノリン | |
| CN110997681B (zh) | 作为腺苷受体拮抗剂的噻唑并吡啶衍生物 | |
| KR20070100331A (ko) | 새로운 아데노신 에이3 수용체 조절제 | |
| US20250214989A1 (en) | Naphthyridinone derivatives for the treatment of a disease or disorder | |
| HU228314B1 (hu) | Kemokin receptor antagonisták, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| CN114276349B (zh) | 2-氨基喋啶酮类衍生物或其盐及其制备方法和用途 | |
| RU2790011C2 (ru) | Тиазолопиридиновые производные в качестве антагонистов аденозиновых рецепторов | |
| RU2791168C1 (ru) | Хиноксалиновые производные в качестве антагонистов аденозиновых рецепторов | |
| WO2025091037A1 (en) | Organic compounds | |
| CN101155785A (zh) | 新型腺苷a3受体调节剂 | |
| WO2025091010A1 (en) | Organic compounds | |
| CZ20004240A3 (cs) | Modulátory adenosinového receptorů A3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20070725 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20101007 Comment text: Request for Examination of Application |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120621 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20121231 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20120621 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |